Reporting Manager
Xiangmin Cui
Symbol
CGON
Shares outstanding
75,853,202 shares
Disclosed Ownership
6,371,669 shares
Ownership
8.4%
Form type
SCHEDULE 13G/A
Filing time
14 Feb 2025, 17:40:02 UTC
Date of event
31 Dec 2024

Quoteable Key Fact

"Decheng Capital Global Life Sciences Fund IV, L.P. disclosed 8.4% ownership in CG ONCOLOGY, INC. Common stock, $0.0001 par value per share (CGON) on 31 Dec 2024."

Quick Takeaways

  • Decheng Capital Global Life Sciences Fund IV, L.P. filed SCHEDULE 13G/A for CG ONCOLOGY, INC. Common stock, $0.0001 par value per share (CGON).
  • Disclosed ownership: 8.4%.
  • Date of event: 31 Dec 2024.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 14 Feb 2025, 17:40.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Decheng Capital Global Life Sciences Fund IV, L.P. 7% 5,315,954 0 5,315,954 /s/ Xiangmin Cui By Decheng Capital Management IV (Cayman), LLC, its General Partner, By Xiangmin Cui, Manager
Decheng Capital Management IV (Cayman), LLC 7% 5,315,954 0 5,315,954 /s/ Xiangmin Cui By Xiangmin Cui, Manager
Decheng Capital Global Healthcare Fund (Master), LP 1.4% 1,055,715 0 1,055,715 /s/ Xiangmin Cui By Decheng Capital Global Healthcare GP, LLC, its General Partner, By Decheng Capital LLC, its Manager, By Xiangmin Cui, Manager
Decheng Capital Global Healthcare GP, LLC 1.4% 1,055,715 0 1,055,715 /s/ Xiangmin Cui By Decheng Capital LLC, its Manager, By Xiangmin Cui, Manager
Xiangmin Cui 8.4% 6,371,669 0 6,371,669 /s/ Xiangmin Cui Xiangmin Cui